A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)
This study has been terminated.
(for efficacy and safety reasons)
Sponsor:
Brown University
Collaborators:
Rhode Island Hospital
Memorial Hospital of Rhode Island
Information provided by:
Brown University
ClinicalTrials.gov Identifier:
NCT00787852
First received: November 7, 2008
Last updated: May 27, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | December 2011 |
| Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |